Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.

Gobbi H, Arteaga CL, Jensen RA, Simpson JF, Dupont WD, Olson SJ, Schuyler PA, Plummer WD, Page DL
Histopathology. 2000 36 (2): 168-77

PMID: 10672063 · DOI:10.1046/j.1365-2559.2000.00841.x

MeSH Terms (18)

Adult Aged Aged, 80 and over Breast Breast Neoplasms Carcinoma, Ductal, Breast Carcinoma in Situ Disease Progression Female Humans Hyperplasia Immunohistochemistry Middle Aged Neoplasm Invasiveness Neoplasm Staging Protein-Serine-Threonine Kinases Receptor, Transforming Growth Factor-beta Type II Receptors, Transforming Growth Factor beta

Connections (2)

This publication is referenced by other Labnodes entities: